OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amyloid-β and Parkinson’s disease
Ee Wei Lim, Dag Aarsland, Dominic ffytche, et al.
Journal of Neurology (2018) Vol. 266, Iss. 11, pp. 2605-2619
Closed Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Prodromal Parkinson disease subtypes — key to understanding heterogeneity
Daniela Berg, Per Borghammer, Seyed‐Mohammad Fereshtehnejad, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 6, pp. 349-361
Closed Access | Times Cited: 272

Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
Maryam Raeeszadeh‐Sarmazdeh, Linh Do, Brianne Hritz
Cells (2020) Vol. 9, Iss. 5, pp. 1313-1313
Open Access | Times Cited: 258

Sleep Deprivation and Neurological Disorders
Muhammed Bishir, Abid Bhat, Musthafa Mohamed Essa, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 156

Amyloid-β: a potential link between epilepsy and cognitive decline
Michele Romoli, Arjune Sen, Lucilla Parnetti, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 8, pp. 469-485
Closed Access | Times Cited: 94

Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain
Lilah Toker, Gia Tuong Tran, Janani Sundaresan, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 89

The role of neuroimaging in Parkinson’s disease
Natasha Bidesi, Ida Vang Andersen, Albert D. Windhorst, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 4, pp. 660-689
Open Access | Times Cited: 88

Histidine modulates amyloid-like assembly of peptide nanomaterials and confers enzyme-like activity
Ye Yuan, Lei Chen, Lingfei Kong, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 33

Epigenetic modification in Parkinson’s disease
Hao Song, Juanli Chen, Jin Huang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 23

The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases
Teresa R. Kee, Sophia Khan, Maya B. Neidhart, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 129-141
Open Access | Times Cited: 11

Associations among sleep quality, sleep duration, and Alzheimer's disease biomarkers: A systematic review and meta‐analysis
Chunlin Chen, Minming Zhang, Zhilin Wang, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1

Predictors of Long‐Term Outcome of Subthalamic Stimulation in Parkinson Disease
Francesco Cavallieri, Valérie Fraix, Francesco Bove, et al.
Annals of Neurology (2020) Vol. 89, Iss. 3, pp. 587-597
Closed Access | Times Cited: 60

The role of amyloids in Alzheimer's and Parkinson's diseases
Parveen Salahuddin, Munazza Fatima, Vladimir N. Uversky, et al.
International Journal of Biological Macromolecules (2021) Vol. 190, pp. 44-55
Open Access | Times Cited: 54

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
Lucia Batzu, Silvia Rota, Abdul Hye, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 37

Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice
Lars Tönges, Carsten Buhmann, Stephan Klebe, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1201-1217
Open Access | Times Cited: 36

Calmodulin binding proteins and neuroinflammation in multiple neurodegenerative diseases
Danton H. O’Day, Robert J. Huber
BMC Neuroscience (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 30

Meta-analysis of the make-up and properties of in vitro models of the healthy and diseased blood–brain barrier
James G. Shamul, Zhiyuan Wang, Hyeyeon Gong, et al.
Nature Biomedical Engineering (2024)
Closed Access | Times Cited: 6

Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders
K. A. Jellinger
Journal of Neural Transmission (2019) Vol. 126, Iss. 8, pp. 933-995
Closed Access | Times Cited: 43

Inflammasomes and Cell Death: Common Pathways in Microparticle Diseases
Maryam Rashidi, Ian P. Wicks, James E. Vince
Trends in Molecular Medicine (2020) Vol. 26, Iss. 11, pp. 1003-1020
Closed Access | Times Cited: 43

Therapeutic Advantages of Nanoparticle-Impregnated Lysozyme Conjugates toward Amyloid-β Fibrillation and Antimicrobial Activity
Jahnabi Upadhyaya, Imocha Rajkumar Singh, Bishal Pun, et al.
The Journal of Physical Chemistry B (2025)
Closed Access

The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms
Angenelle Eve Rosal, Sarah L. Martin, Antonio P. Strafella
Frontiers in Neuroscience (2025) Vol. 19
Open Access

Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177419-177419
Open Access

Biofilm-Associated Amyloid Proteins Linked with the Progression of Neurodegenerative Diseases
Alka Ashok Singh, Fazlurrahman Khan, Minseok Song
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2695-2695
Open Access

Cognitive impairment and World Trade Centre-related exposures
Sean Clouston, Charles B. Hall, Minos Kritikos, et al.
Nature Reviews Neurology (2021) Vol. 18, Iss. 2, pp. 103-116
Open Access | Times Cited: 32

Page 1 - Next Page

Scroll to top